Fortress Biotech
FBIO
49 hedge funds and large institutions have $9.23M invested in Fortress Biotech in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 8 closing their positions.
38% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 8
33% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 12
20% more capital invested
Capital invested by funds: $7.66M → $9.23M (+$1.56M)
11% more call options, than puts
Call options by funds: $152K | Put options by funds: $137K
7% more funds holding
Funds holding: 46 → 49 (+3)
1.02% less ownership
Funds ownership: 17.79% → 16.78% (-1%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SF
Summit Financial
Parsippany,
New Jersey
|
+$1.76M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$192K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$174K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$99.3K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$86.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$1.57M |
| 2 |
PAM
PVG Asset Management
Golden,
Colorado
|
-$260K |
| 3 |
HWM
HB Wealth Management
Atlanta,
Georgia
|
-$177K |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
-$170K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$125K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HWM
51
HB Wealth Management
Atlanta,
Georgia
| – | -$177K | -113,350 | Closed |
|
52
Group One Trading
Chicago,
Illinois
| – | -$77.6K | -44,820 | Closed |
|
53
Renaissance Technologies
New York
| – | -$49.9K | -32,000 | Closed |
|
|
AG
54
AmeriFlex Group
Las Vegas,
Nevada
| – | -$6.86K | -4,400 | Closed |
|
55
Fidelity Investments
Boston,
Massachusetts
| – | -$3.04K | -1,950 | Closed |
|
56
Citigroup
New York
| – | -$301 | -193 | Closed |
|
57
Wells Fargo
San Francisco,
California
| – | -$25 | -16 | Closed |
|
FBIO Hedge Fund Activity: Q2 2025 in Review
49 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q2 2025, worth a combined $9.23M — up 20% from $7.66M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new FBIO positions and 8 closed out — a net gain of 3 holders — while 16 added to existing stakes and 12 trimmed.
The largest buyer was Summit Financial, opening a new position worth an estimated $1.76M. The largest seller was Cambridge Investment Research Advisors, exiting entirely with an estimated $1.57M sold.
- 49 institutional investors held Fortress Biotech (FBIO) as of Q2 2025, up from 46 in Q1 2025.
- Funds reported $9.23M of Fortress Biotech stock for Q2 2025, up 20% quarter-over-quarter.
- 11 funds opened new Fortress Biotech positions in Q2 2025 and 8 closed out, a net change of +3 holders.
- The largest Fortress Biotech buyer in Q2 2025 was Summit Financial, an estimated $1.76M added.
- The largest Fortress Biotech seller in Q2 2025 was Cambridge Investment Research Advisors, an estimated $1.57M sold.
Based on aggregated 13F filings for Q2 2025.